CME Credit for Physicians
Physicians: CLICK HERE to claim CME credit.
Accreditation Statement
The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
The American Association for the Study of Liver Diseases (AASLD) designates this Other activity (combination of live course and enduring materials) for a maximum of 165.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with their participation in the activity.
Credit Claiming Period
Credit Claiming for The Liver Meeting 2024 will open on November 15. The following is the process to be completed once appropriate.
Medium and Method of Physician Participation
- Register for The Liver Meeting® this summer
- Attend The Liver Meeting® in San Diego, CA and/or view live streamed sessions online between November 15-19, 2024.
- View recordings of sessions presented in person at The Liver Meeting® online between November 15 and December 15, 2024 if desired.
- Complete the meeting evaluation and identify all completed sessions (when available)
- Print and/or download a CME certificate if desired.
Other Healthcare Providers
Nurses and Pharmacists
Nurses and Pharmacists: CLICK HERE to claim credit.
Nurses and Pharmacists-Learner Notification
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Association for the Study of Liver Diseases. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 21.25 ANCC contact hours.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 21.25 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
Nurse Pharmacology Credits
Please note onsite agenda for identification of sessions eligible for pharmacotherapeutic hours and self-submit those to your board. Keep the agenda as a reference in case they have questions.
Other Advanced Providers
The AAPA, ANCC and AANP accept reports from advanced practitioners of their participation in activities offering AMA PRA Category 1 CreditsTM for continuing education and credentialing purposes. For more information, please contact the appropriate organization.
Questions
Questions related to credit claiming should be directed to Education@aasld.org
CME Session Credits
This list of CME credits awarded for each of the different sessions offered at TLM 2024 is not yet available.
Commercial Support
The Liver Meeting 2024 is supported by independent medical educational grants from Gilead Sciences, GSK, Ipsen, Mallinckrodt, and Salix Pharmaceuticals; and in-kind support from Butterfly, Clarius, Fujifilm/Sonosite, GE Healthcare, Mindray, Samsung, Siemens, and SuperSonic Imagine.
Learning Objectives
Learning Objectives for sessions offered at The Liver Meeting can be viewed in the online program available on The Liver Meeting website or in the meeting’s mobile app, when they become available later this year.
Disclosure of Financial Relationships and Conflicts of Interest
This educational activity has been planned in accordance with the AASLD Financial Disclosure Policy and ACCME Standards for the Integrity and Independence for Accredited Continuing Education by members of the AASLD Transplant Hepatology Board Review Course faculty, the AASLD Maintenance of Certification Committee and the AASLD Governing Board. As an accredited provider, AASLD must collect information from all planners, faculty and others in the planning and control of continuing medical education (CME) activities to disclose all of their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. There is no minimum financial threshold; individuals must disclose all financial relationships, regardless of the amount, in ineligible companies. Individuals must disclose financial relationships with ineligible companies regardless of their view of the relevance of the relationship to the education.
The American Association for the Study of Liver Diseases (AASLD) has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair balanced, independent, and free of commercial bias. Conflicts, if any, are resolved through one or more processes. All relevant conflicts pertaining to this activity have been mitigated.
When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, the speaker shall disclose to the audience that the product is not labeled for the use under discussion or that the product is still investigational.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of AASLD. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Below are lists of all involved in content development along with their financial disclosures. All other faculty, planners, committee members and staff have nothing to disclose.